University hospitals in Paris have signed a three-year deal with Sanofi, a pharmaceutical company, to increase cooperation on clinical trials.
Sanofi and AP-HP, an association of 39 university hospitals in the Paris region, published the first details of the deal in a joint statement on 3 May.
Under the deal, Sanofi will inform the AP-HP of its plans for forthcoming trials, and seek greater involvement of AP-HP hospitals with early feasibility studies.
This article is only available to Research Professional News subscribers or Pivot-RP users.
If you are a Research Professional News subscriber you can log in and view the article via this link
Pivot-RP users can log in and view the article via this link.